C83.0A
Small cell B-cell lymphoma, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Small cell B-cell lymphoma is a type of blood cancer that affects the lymphatic system, which is part of the body's immune system. When diagnosed, treatment may lead to remission, meaning the signs and symptoms of cancer have reduced significantly or disappeared. The ICD-10 code C83.0A specifically refers to small cell B-cell lymphoma that is currently in remission. While remission is a positive development, ongoing monitoring and care are essential to manage the condition effectively.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal growth of B lymphocytes Infections that may trigger immune responses associated with lymphoma Environmental exposures such as certain chemicals or radiation (though specific causes are often unclear) Age-related changes in immune system function
Key Symptoms: Swollen lymph nodes, often painless, in the neck, armpits, or groin Unexplained weight loss Persistent fatigue or weakness Fever or chills without an apparent cause Night sweats Frequent infections due to weakened immune function
Diagnostic & Treatment
Diagnosis Path: Diagnosis of small cell B-cell lymphoma generally involves several steps. Doctors often perform a physical exam to check for enlarged lymph nodes and other signs. Blood tests can help assess overall health and detect abnormal cells. A biopsy, where a small tissue sample from a lymph node or other affected area is examined under a microscope, confirms the diagnosis. Additional imaging tests such as CT scans, PET scans, or MRI may be used to determine the extent of the disease. Once diagnosed, ongoing evaluations are essential to monitor remission status, including regular blood work and imaging.
Treatment Protocols: While the exact treatment plan varies based on individual circumstances, common approaches include chemotherapy, targeted therapy, immunotherapy, and sometimes radiation therapy. These treatments aim to eliminate cancer cells, induce remission, and maintain it for as long as possible. In cases of remission, healthcare providers continue to monitor the patient regularly through follow-up appointments, blood tests, and scans to detect any signs of recurrence early. Supportive care measures, such as managing side effects and improving quality of life, are integral parts of the overall treatment plan.
Clinical Advice & FAQs
Billing Guidance
Is C83.0A a billable ICD-10 code?
Yes, C83.0A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.0A?
Clinical documentation must specify the nature of Small cell B-cell lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference